Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Crohn’s disease

UKRI’s MRC awards £27.4m to University of Dundee research unit

UKRI’s MRC awards £27.4m to University of Dundee research unit
p p Read More

The centre aims to discover new drug targets for diseases such as Parkinson’s and hypertension

September 17, 2024 Crohn’s disease, MRC, MRC PPU, News, parkinsons, UKRI, University of Dundee

Study identifies new disease-inducing mechanism for inflammatory bowel disease

Study identifies new disease-inducing mechanism for inflammatory bowel disease
p p Read More

Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK

August 15, 2024 Crohn’s disease, Great North Children's Hospital, IL10, Inflammatory Bowel Disease, Newcastle University, News, Ulcerative Colitis, University of Cambridge, university of oxford

Lab-grown ‘mini guts’ to help identify treatment for Crohn’s disease

Lab-grown ‘mini guts’ to help identify treatment for Crohn’s disease
p p Read More

The lifelong inflammatory bowel disease affects around one in every 350 people in the UK

June 20, 2024 Crohn’s disease, Inflammatory Bowel Disease, News, organoids, University of Cambridge

Francis Crick researchers reveal pathways linking intestinal inflammation and colitis

Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis

April 15, 2024 Blimp-1, Crohn’s disease, Francis Crick Institute, IL-10, Inflammatory Bowel Disease, News, Ulcerative Colitis

‘Top-down’ treatment strategy dramatically improves outcomes for Crohn’s patients

Approximately 80% of patients taking Remicade from diagnosis had symptoms controlled

February 29, 2024 Crohn’s disease, infliximab, News, PROFILE, Remicade, University of Cambridge
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy